Blood Culture Tests Market by Method (Conventional, Automated), Product (Consumables, Instruments), Technology (Culture, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospitals, Reference Labs) & Region- Global Forecast to 2028

Abstract
The global blood culture tests is projected to reach USD 7.6 billion by 2028 from USD 5.2 billion in 2023, at a CAGR of 8.0% during the forecast period. Growth in this market is majorly driven by the rising geriatric population, growing incidence of sepsis cases and high cost treatment, high incidence of blood stream infections, growing demand for rapid diagnostic techniques and high prevalence of infectious diseases. However, high cost of automated instruments and lack of trained laboratory technicians are expected to restrain the market growth in the upcoming years.

The automated blood culture tests segment is projected to grow at the highest CAGR during the forecast period.

Based on method, the market for blood culture tests is divided into segments for automated blood culture method and conventional/manual blood culture method. The automated blood culture tests segment is projected to grow at the highest CAGR during the forecast period. Key factors driving revenue growth for automated blood culture equipment is the ability to expedite infection identification and treatment, quick turnaround time and reduced risk of contamination due to low manual intervention. Consequently, timely identification allows for prompt initiation of targeted treatments, leading to improved patient outcomes and shorter hospital stays.

The consumables segment is the largest share of the market during the forecast period.

Based on product, the blood culture tests is broadly segmented into, instruments, consumables, and software and services. The consumables segment accounted for the largest share and this is attributed to the repeated purchase of media for the detection of yeast, bacteria and fungi and increase in drug-resistant infections, such as methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL)-producing bacteria.

The molecular technology segment accounted for the second largest share of the market.

Based on technology, the blood culture tests is broadly segmented into proteomics, culture-based technologies and molecular technologies. Due to its largest and fastest growing segment which is the microarray segment, the molecular technologies market is accounted for the second largest share of the blood culture tests market. This can be attributed to the increasing incidence of sepsis, which demands rapid diagnostic techniques for detecting the presence of bacteria, fungi, and mycobacteria from blood samples.

The bacteremia segment accounted for the largest share of the market.

Based on applications, the blood culture tests is broadly segmented into mycobacterial detection, bacteremia and fungemia. Bacteremia segment has accounted for the largest share of the blood culture tests market. The main reason for this is the increasing number of bloodstream infections and the growing number of sepsis cases worldwide. Sepsis and septic shock is associated with a high morbidity rate (which can result in a prolonged hospital stay and increase the associated healthcare costs) and mortality rate. Patients with implanted devices; endotracheal tubes; chronic healthcare conditions such as diabetes, cancer, and diseases of the kidney and liver; and those with suppressed immune systems are more prone to developing sepsis.

The reference laboratories segment is projected to have the highest CAGR.

Based on end users, the bloodculture tests market is divided into academic research laboratories, hospital laboratories, reference laboratories, and other laboratories (involves independent research laboratories, pathology laboratories, bacteriological laboratories, and physician office laboratories (POLs). The reference laboratories segment is projected to grow at the highest rate in this market. This is due to the increasing outsourcing of blood culture tests by hospitals to reference laboratories.

Europe accounted for the second largest share of the blood culture tests market.

Europe accounted for the second largest share of the blood culture tests . Growth in the European market is driven by the increasing number of sepsis cases, high healthcare expenditure, rapidly growing geriatric population, growing regulatory approvals, and strong government support in this region. Healthcare costs have risen exponentially in Europe, and various initiatives to raise funds to cover healthcare costs have proven inadequate.

The break-up of the profile of primary participants in the blood culture tests market:
•By Company Type: Tier 1- 60%, Tier 2- 30%, and Tier 3- 10%
•By Designation: C-Level Executives- 50%, Directors-40%, and Others-10%
•By Region: North America- 45% , Europe- 35%, Asia-Pacific- 15%, and Rest of the World- 5%

Key players in the Blood culture tests
The key players operating in the blood culture tests include Danaher (US), Luminex Corporation (US), Bruker (US), Roche Diagnostics (Switzerland), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Terumo Corporation (Japan), Becton, Dickinson and Company (US), BioMérieux (France), Himedia Laboratories Pvt. Ltd. (India), Autobio Diagnostics Co., Ltd. (China), Axiom Laboratories (India), Mikroscan Technologies, Inc. (US), Labotronics Ltd. (UK), Hardy Diagnostics (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Iridica (US), Thermo Fisher Scientific Inc. (US), Biosystems, Inc (US), BINDER GmBH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio (England), and Anaerobe Systems, Inc. (US).

Research Coverage:
The report analyzes the blood culture tests and aims at estimating the market size and future growth potential of this market based on various segments such as method, product, technology, application, end user, and region. The report also includes a product portfolio matrix of various blood culture tests products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Analysis of Key drivers (growing incidences of sepsis cases and high cost of treatment, rising geriatric population, high incidence of bloodstream infections, growing demand for rapid diagnostic techniques, and the high prevalence of infectious diseases), restraints (high cost of automated instruments and lack of trained laboratory technicians are limiting the growth of this market), opportunities (growth opportunities in emerging economies, identification of antibiotic resistance microorganisms), and challenges ( market cannibalization, survival of new entrants).
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the global blood culture tests . The report analyzes this market by. method, product, technology, application, end user.
•Service Enhancement/Innovation: Detailed insights on upcoming trends in the global blood culture tests.
•Market Development: Comprehensive information on the lucrative emerging markets by method, product, technology, application, end user.
•Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global blood culture tests.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global blood culture tests.

Content
Table of Contents

1INTRODUCTION39
1.1STUDY OBJECTIVES39
1.2MARKET DEFINITION39
1.2.1INCLUSIONS AND EXCLUSIONS40
1.3MARKET SCOPE41
1.3.1MARKETS COVERED41
1.3.2REGIONS COVERED42
1.4YEARS CONSIDERED42
1.5CURRENCY CONSIDERED42
TABLE 1STANDARD CURRENCY CONVERSION RATES43
1.6STAKEHOLDERS43
1.7SUMMARY OF CHANGES43
1.8IMPACT OF RECESSION: BLOOD CULTURE TESTS MARKET44
2RESEARCH METHODOLOGY45
2.1RESEARCH APPROACH45
FIGURE 1RESEARCH DESIGN45
2.1.1SECONDARY DATA46
2.1.1.1Key data from secondary sources46
2.1.2PRIMARY DATA47
FIGURE 2PRIMARY SOURCES47
2.1.2.1Key data from primary sources48
2.1.2.2Insights from primary experts48
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION49
2.2MARKET SIZE ESTIMATION49
FIGURE 4MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS50
FIGURE 5SEGMENTAL EXTRAPOLATION: GLOBAL BLOOD CULTURE TESTS MARKET (2022)50
FIGURE 6CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)52
FIGURE 7CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS52
2.3APPROACH TO DETERMINE IMPACT OF ECONOMIC RECESSION53
2.4MARKET BREAKDOWN AND DATA TRIANGULATION54
FIGURE 8MARKET DATA TRIANGULATION METHODOLOGY54
2.5MARKET SHARE ANALYSIS55
2.6STUDY ASSUMPTIONS55
2.7RESEARCH LIMITATIONS55
2.7.1METHODOLOGY-RELATED LIMITATIONS55
2.7.2SCOPE-RELATED LIMITATIONS55
2.8RISK ASSESSMENT56
TABLE 2RISK ASSESSMENT: BLOOD CULTURE TESTS MARKET56
3EXECUTIVE SUMMARY57
FIGURE 9BLOOD CULTURE TESTS MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)57
FIGURE 10BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)58
FIGURE 11BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)58
FIGURE 12BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)59
FIGURE 13BLOOD CULTURE TESTS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)59
FIGURE 14GEOGRAPHICAL SNAPSHOT OF BLOOD CULTURE TESTS MARKET60
4PREMIUM INSIGHTS61
4.1BLOOD CULTURE TESTS MARKET OVERVIEW61
FIGURE 15GROWING INCIDENCE OF SEPSIS CASES AND HIGH COST OF TREATMENT TO DRIVE MARKET61
4.2BLOOD CULTURE TESTS MARKET, BY PRODUCT62
FIGURE 16CONSUMABLES SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD62
4.3ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD AND COUNTRY (2022)62
FIGURE 17CONVENTIONAL/MANUAL BLOOD CULTURE SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC BLOOD CULTURE TESTS MARKET IN 202262
4.4BLOOD CULTURE TESTS MARKET: REGIONAL MIX63
FIGURE 18CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD63
4.5BLOOD CULTURE TESTS MARKET: DEVELOPED VS. EMERGING ECONOMIES63
FIGURE 19EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD63
5MARKET OVERVIEW64
5.1INTRODUCTION64
FIGURE 20BLOOD CULTURE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES64
5.1.1DRIVERS65
5.1.1.1Increasing number of sepsis patients and rising cost of treatment65
TABLE 3US: FIVE MOST EXPENSIVE CONDITIONS TREATED IN HOSPITALS65
5.1.1.2Rapid growth in geriatric population with chronic diseases65
TABLE 4GERIATRIC POPULATION: KEY STATISTICS66
5.1.1.3High incidence of nosocomial bloodstream infections66
5.1.1.4Growing demand for rapid diagnostic techniques with faster turnaround times66
5.1.1.5High prevalence of infectious diseases globally67
5.1.2RESTRAINTS68
5.1.2.1High cost of automated blood culture instruments68
5.1.2.2Lack of trained laboratory technicians68
5.1.3OPPORTUNITIES68
5.1.3.1Growth opportunities in emerging economies68
5.1.3.2Increased need to identify antibiotic-resistant microorganisms69
5.1.4CHALLENGES69
5.1.4.1Market cannibalization for conventional products69
5.1.4.2Difficulty in survival of new entrants69
5.2INDUSTRY TRENDS70
5.2.1LABORATORY AUTOMATION FOR INCREASED EFFICIENCY AND ACCURATE DIAGNOSIS70
5.2.2FOCUS ON ANTIMICROBIAL STEWARDSHIP70
5.3TECHNOLOGY ANALYSIS71
5.3.1ADVANCED FLUORESCENCE DETECTION TECHNOLOGY71
5.4AVERAGE SELLING PRICE, BY TYPE71
5.4.1AVERAGE SELLING PRICE FOR BLOOD CULTURE TEST PRODUCTS, BY KEY PLAYER (2022)72
TABLE 5REGIONAL PRICING ANALYSIS OF BLOOD CULTURE TEST PRODUCTS, BY TYPE, 2021 (USD)72
5.5VALUE CHAIN ANALYSIS73
FIGURE 21MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES73
5.6SUPPLY CHAIN ANALYSIS74
FIGURE 22SUPPLY CHAIN ANALYSIS: BLOOD CULTURE TESTS MARKET74
5.7ECOSYSTEM MAPPING75
FIGURE 23ECOSYSTEM MAPPING: BLOOD CULTURE TESTS MARKET75
5.8PORTER’S FIVE FORCES ANALYSIS75
TABLE 6PORTER’S FIVE FORCES ANALYSIS: BLOOD CULTURE TESTS MARKET75
5.8.1THREAT OF NEW ENTRANTS76
5.8.2THREAT OF SUBSTITUTES76
5.8.3BARGAINING POWER OF BUYERS76
5.8.4BARGAINING POWER OF SUPPLIERS76
5.8.5INTENSITY OF COMPETITIVE RIVALRY76
5.9TARIFF AND REGULATORY ANALYSIS77
5.9.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS77
TABLE 7LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS77
5.9.2REGULATORY ANALYSIS77
5.9.2.1North America77
5.9.2.1.1US77
TABLE 8US FDA: MEDICAL DEVICE CLASSIFICATION78
TABLE 9US: TIME, COST, AND COMPLEXITY OF REGISTRATION78
5.9.2.1.2Canada78
TABLE 10CANADA: CLASSIFICATION OF PRODUCTS78
TABLE 11CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION79
5.9.2.2Europe79
TABLE 12EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES79
5.9.3ASIA PACIFIC80
5.9.3.1Japan80
5.9.3.2China80
5.9.3.3India80
5.10PATENT ANALYSIS81
5.10.1PATENT PUBLICATION TRENDS FOR BLOOD CULTURE TESTS MARKET81
FIGURE 24PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023)81
5.10.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS81
FIGURE 25TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR BLOOD CULTURE TEST PATENTS (JANUARY 2011–JUNE 2023)82
FIGURE 26TOP APPLICANTS FOR BLOOD CULTURE TEST PATENTS (COUNTRY/REGION) (JANUARY 2011–JULY 2023)82
TABLE 13BLOOD CULTURE TESTS MARKET: LIST OF PATENTS (2020–2023)83
5.11KEY CONFERENCES AND EVENTS IN 2023–202484
TABLE 14BLOOD CULTURE TESTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–202484
5.12KEY STAKEHOLDERS AND BUYING CRITERIA85
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS85
FIGURE 27INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN BLOOD CULTURE TESTS MARKET85
TABLE 15INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN BLOOD CULTURE TESTS MARKET (%)85
5.12.2BUYING CRITERIA86
FIGURE 28KEY BUYING CRITERIA FOR BLOOD CULTURE TEST METHODS86
TABLE 16KEY BUYING CRITERIA FOR BLOOD CULTURE TEST METHODS86
6BLOOD CULTURE TESTS MARKET, BY METHOD87
6.1INTRODUCTION88
TABLE 17BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)88
6.2CONVENTIONAL/MANUAL BLOOD CULTURE88
6.2.1CONVENTIONAL/MANUAL BLOOD CULTURE METHOD TO ACCOUNT FOR LARGER SHARE OF BLOOD CULTURE TESTS MARKET88
TABLE 18EXAMPLES OF CONVENTIONAL/MANUAL BLOOD CULTURE PRODUCTS89
TABLE 19BLOOD CULTURE TESTS MARKET FOR CONVENTIONAL/MANUAL BLOOD CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)90
6.3AUTOMATED BLOOD CULTURE90
6.3.1INCREASED R&D INVESTMENTS BY MANUFACTURERS FOR DEVELOPING NOVEL PRODUCTS TO DRIVE MARKET90
TABLE 20EXAMPLES OF AUTOMATED BLOOD CULTURE PRODUCTS91
TABLE 21BLOOD CULTURE TESTS MARKET FOR AUTOMATED BLOOD CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)92
7BLOOD CULTURE TESTS MARKET, BY PRODUCT93
7.1INTRODUCTION94
TABLE 22BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)94
7.2CONSUMABLES94
TABLE 23BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)94
TABLE 24BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)95
7.2.1BLOOD CULTURE MEDIA95
TABLE 25EXAMPLES OF BLOOD CULTURE MEDIA96
TABLE 26BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)96
TABLE 27BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)97
7.2.1.1Aerobic blood culture media97
7.2.1.1.1Aerobic blood culture media to be fastest-growing segment of blood culture media market during forecast period97
TABLE 28AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)98
7.2.1.2Pediatric aerobic blood culture media98
7.2.1.2.1Increased need to recover pathogens from bloodstream of children to drive segment98
TABLE 29PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)99
7.2.1.3Anaerobic blood culture media99
7.2.1.3.1Increased need for routine diagnosis of bacteria in blood culture to drive segment99
TABLE 30ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)100
7.2.1.4Mycobacterial blood culture media100
7.2.1.4.1Rising prevalence of tuberculosis to drive segment100
TABLE 31MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)101
7.2.1.5Fungi/yeast blood culture media101
7.2.1.5.1Easy identification and characterization of special fungal species to drive segment101
TABLE 32FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)102
7.2.2ASSAY KITS & REAGENTS102
7.2.2.1Increased need for rapid identification of bacteria and yeast from positive blood cultures to drive market102
TABLE 33EXAMPLES OF BLOOD CULTURE ASSAY KITS & REAGENTS103
TABLE 34ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)103
7.2.3BLOOD CULTURE ACCESSORIES104
7.2.3.1Growing number of blood culture tests to drive market104
TABLE 35EXAMPLES OF BLOOD CULTURE ACCESSORIES104
TABLE 36BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)105
7.3INSTRUMENTS105
TABLE 37BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)106
7.3.1AUTOMATED BLOOD CULTURE SYSTEMS106
7.3.1.1Need for automated imaging systems and advanced algorithms to drive market106
TABLE 38EXAMPLES OF AUTOMATED BLOOD CULTURE SYSTEMS107
TABLE 39AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)107
7.3.2SUPPORTING LABORATORY EQUIPMENT108
TABLE 40SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)108
TABLE 41SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)108
7.3.2.1Incubators109
7.3.2.1.1Incubators to provide optimal environment with adequate temperature and oxygen levels for microbial growth109
TABLE 42INCUBATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)109
7.3.2.2Colony counters110
7.3.2.2.1Colony counters to increase direct image scanning and analysis capability110
TABLE 43COLONY COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)110
7.3.2.3Microscopes111
7.3.2.3.1Favorable funding scenario for R&D and technological advancements to drive segment111
TABLE 44MICROSCOPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)111
7.3.2.4Gram stainers112
7.3.2.4.1Gram strainers to guide initial antibiotic section and appropriate empirical therapy112
TABLE 45GARAM STAINERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)113
7.4SOFTWARE & SERVICES113
7.4.1INCREASED NEED FOR AUTOMATED SYSTEMS IN HOSPITAL-BASED LABORATORIES TO DRIVE MARKET113
TABLE 46BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)114
8BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY115
8.1INTRODUCTION116
TABLE 47BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)116
8.2CULTURE-BASED TECHNOLOGIES116
8.2.1DRAWBACKS ASSOCIATED WITH TRADITIONAL CULTURE-BASED TECHNOLOGIES TO LIMIT MARKET116
8.3TOP OF FORM117
TABLE 48BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)117
8.3.1MOLECULAR TECHNOLOGIES117
TABLE 49BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)118
TABLE 50BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)119
8.3.2MICROARRAYS119
8.3.2.1Determination of better genotyping characterization and identification of bacterial infections to drive segment119
TABLE 51MICROARRAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)120
8.3.3PCR120
8.3.3.1Reduced risk of contaminations and easy detection of bloodstream infections to drive segment120
TABLE 52PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION)121
8.3.4PNA-FISH121
8.3.4.1PNA-FISH to use genetic markers for analysis of pathogens directly from whole blood samples121
TABLE 53PNA-FISH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)122
8.4PROTEOMICS122
8.4.1PROTEOMICS TO CONTROL INFECTIOUS DISEASES AND ANALYZE COMPLEX MICROBIAL SYSTEMS WITHIN HUMAN FLUIDS122
TABLE 54BLOOD CULTURE TESTS MARKET FOR PROTEOMICS, BY COUNTRY, 2021–2028 (USD MILLION)123
TABLE 55EXAMPLES OF MALDI-TOF MS SYSTEMS124
9BLOOD CULTURE TESTS MARKET, BY APPLICATION125
9.1INTRODUCTION126
TABLE 56BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028(USD MILLION)126
9.2BACTEREMIA126
9.2.1GROWING INCIDENCE OF SEPSIS CASES GLOBALLY TO DRIVE MARKET126
TABLE 57BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2021–2028 (USD MILLION)127
9.3FUNGEMIA127
9.3.1INCREASING INCIDENCE OF BLOODSTREAM INFECTIONS TO DRIVE MARKET127
TABLE 58BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2021–2028 (USD MILLION)128
9.4MYCOBACTERIAL DETECTION128
9.4.1RISING GERIATRIC POPULATION WITH TUBERCULOSIS TO DRIVE MARKET128
TABLE 59BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2021–2028 (USD MILLION)129
10BLOOD CULTURE TESTS MARKET, BY END USER130
10.1INTRODUCTION131
TABLE 60BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)131
10.2HOSPITAL LABORATORIES131
10.2.1INCREASED ABILITY TO CONDUCT LARGE VOLUME OF BLOOD CULTURE TESTS TO DRIVE MARKET131
TABLE 61BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)132
10.3REFERENCE LABORATORIES133
10.3.1INCREASING REQUIREMENT OF ROUTINE AND SPECIALTY TESTS TO DRIVE MARKET133
TABLE 62BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)134
10.4ACADEMIC RESEARCH LABORATORIES134
10.4.1INCREASING FOCUS ON R&D OF INNOVATIVE TESTS FOR BLOODSTREAM INFECTIONS TO DRIVE MARKET134
TABLE 63BLOOD CULTURE TESTS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)135
10.5OTHER LABORATORIES135
TABLE 64BLOOD CULTURE TESTS MARKET FOR OTHER LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)136
11BLOOD CULTURE TESTS MARKET, BY REGION137
11.1INTRODUCTION138
TABLE 65BLOOD CULTURE TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)138
11.2NORTH AMERICA138
FIGURE 29NORTH AMERICA: BLOOD CULTURE TESTS MARKET SNAPSHOT139
TABLE 66NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)139
TABLE 67NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)140
TABLE 68NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)140
TABLE 69NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)140
TABLE 70NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)141
TABLE 71NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)141
TABLE 72NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)141
TABLE 73NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)142
TABLE 74NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)142
TABLE 75NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)142
TABLE 76NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)143
11.2.1US143
11.2.1.1US to dominate blood culture tests market during study period143
TABLE 77US: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)144
TABLE 78US: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)144
TABLE 79US: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)144
TABLE 80US: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)145
TABLE 81US: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)145
TABLE 82US: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)145
TABLE 83US: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)146
TABLE 84US: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)146
TABLE 85US: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)146
TABLE 86US: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)147
11.2.2CANADA147
11.2.2.1Increasing incidence of bloodstream infections to drive market147
TABLE 87CANADA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)147
TABLE 88CANADA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)148
TABLE 89CANADA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)148
TABLE 90CANADA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)148
TABLE 91CANADA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)149
TABLE 92CANADA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)149
TABLE 93CANADA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)149
TABLE 94CANADA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)150
TABLE 95CANADA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)150
TABLE 96CANADA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)150
11.2.3NORTH AMERICA: RECESSION IMPACT151
11.3EUROPE151
TABLE 97EUROPE: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)152
TABLE 98EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)152
TABLE 99EUROPE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)152
TABLE 100EUROPE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)153
TABLE 101EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)153
TABLE 102EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)153
TABLE 103EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)154
TABLE 104EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)154
TABLE 105EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)154
TABLE 106EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)155
TABLE 107EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)155
11.3.1GERMANY155
11.3.1.1Germany commanded largest share of European blood culture tests market in 2022155
TABLE 108GERMANY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)156
TABLE 109GERMANY: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)156
TABLE 110GERMANY: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)156
TABLE 111GERMANY: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)157
TABLE 112GERMANY: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)157
TABLE 113GERMANY: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)157
TABLE 114GERMANY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)158
TABLE 115GERMANY: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)158
TABLE 116GERMANY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)158
TABLE 117GERMANY: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)159
11.3.2UK159
11.3.2.1High burden of sepsis and increased geriatric population to drive market159
TABLE 118UK: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)160
TABLE 119UK: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)160
TABLE 120UK: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)160
TABLE 121UK: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)161
TABLE 122UK: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)161
TABLE 123UK: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)161
TABLE 124UK: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)162
TABLE 125UK: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)162
TABLE 126UK: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)162
TABLE 127UK: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)163
11.3.3FRANCE163
11.3.3.1Rising geriatric population and favorable government regulations to drive market163
TABLE 128FRANCE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)163
TABLE 129FRANCE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)164
TABLE 130FRANCE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)164
TABLE 131FRANCE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)164
TABLE 132FRANCE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)165
TABLE 133FRANCE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)165
TABLE 134FRANCE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)165
TABLE 135FRANCE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)166
TABLE 136FRANCE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)166
TABLE 137FRANCE: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)166
11.3.4ITALY167
11.3.4.1Slow growth in healthcare sector with increased health expenditure to limit market167
TABLE 138ITALY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)167
TABLE 139ITALY: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)167
TABLE 140ITALY: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)168
TABLE 141ITALY: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)168
TABLE 142ITALY: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)168
TABLE 143ITALY: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)169
TABLE 144ITALY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)169
TABLE 145ITALY: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)169
TABLE 146ITALY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)170
TABLE 147ITALY: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)170
11.3.5SPAIN170
11.3.5.1Rapid increase in diagnostic procedures and improved healthcare infrastructure to drive market170
TABLE 148SPAIN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)171
TABLE 149SPAIN: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)171
TABLE 150SPAIN: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)171
TABLE 151SPAIN: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)172
TABLE 152SPAIN: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)172
TABLE 153SPAIN: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)172
TABLE 154SPAIN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)173
TABLE 155SPAIN: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)173
TABLE 156SPAIN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)173
TABLE 157SPAIN: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)174
11.3.6REST OF EUROPE174
TABLE 158REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)174
TABLE 159REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)175
TABLE 160REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)175
TABLE 161REST OF EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)175
TABLE 162REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)176
TABLE 163REST OF EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)176
TABLE 164REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)176
TABLE 165REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)177
TABLE 166REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)177
TABLE 167REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)177
11.3.7EUROPE: RECESSION IMPACT178
11.4ASIA PACIFIC178
FIGURE 30ASIA PACIFIC: BLOOD CULTURE TESTS MARKET SNAPSHOT179
TABLE 168ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)180
TABLE 169ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)180
TABLE 170ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)180
TABLE 171ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)181
TABLE 172ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)181
TABLE 173ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)181
TABLE 174ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)182
TABLE 175ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)182
TABLE 176ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)182
TABLE 177ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)183
TABLE 178ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)183
11.4.1JAPAN183
11.4.1.1Japan to be largest market for blood culture tests in Asia Pacific183
TABLE 179JAPAN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)184
TABLE 180JAPAN: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)184
TABLE 181JAPAN: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)184
TABLE 182JAPAN: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)185
TABLE 183JAPAN: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)185
TABLE 184JAPAN: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)186
TABLE 185JAPAN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)186
TABLE 186JAPAN: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)186
TABLE 187JAPAN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)187
TABLE 188JAPAN: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)187
11.4.2CHINA187
11.4.2.1Rapid economic growth and rising disposable income of middle-class population to drive market187
TABLE 189CHINA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)188
TABLE 190CHINA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)188
TABLE 191CHINA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)188
TABLE 192CHINA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)189
TABLE 193CHINA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)189
TABLE 194CHINA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)189
TABLE 195CHINA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)190
TABLE 196CHINA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)190
TABLE 197CHINA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)190
TABLE 198CHINA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)191
11.4.3INDIA191
11.4.3.1Rising prevalence of infectious diseases and growing geriatric population to drive market191
TABLE 199INDIA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)192
TABLE 200INDIA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)192
TABLE 201INDIA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)192
TABLE 202INDIA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)193
TABLE 203INDIA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)193
TABLE 204INDIA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)193
TABLE 205INDIA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)194
TABLE 206INDIA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)194
TABLE 207INDIA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)194
TABLE 208INDIA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)195
11.4.4REST OF ASIA PACIFIC195
TABLE 209REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)195
TABLE 210REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)196
TABLE 211REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)196
TABLE 212REST OF ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)196
TABLE 213REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)197
TABLE 214REST OF ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)197
TABLE 215REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)197
TABLE 216REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)198
TABLE 217REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)198
TABLE 218REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)198
11.4.5ASIA PACIFIC: RECESSION IMPACT199
11.5LATIN AMERICA199
11.5.1FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET199
11.5.2LATIN AMERICA: RECESSION IMPACT200
TABLE 219LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021–2028 (USD MILLION)200
TABLE 220LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)200
TABLE 221LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)201
TABLE 222LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)201
TABLE 223LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)201
TABLE 224LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)202
TABLE 225LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)202
TABLE 226LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021–2028 (USD MILLION)202
TABLE 227LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)203
TABLE 228LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021–2028 (USD MILLION)203
11.6MIDDLE EA